RELATED CONTENT
NEWS
- Novartis eyes new product push in India as it girds for Glivec case
- Zydus sets sight on US controlled substances market via Nesher buy
- End of an era in antibiotic blockbusters as FDA approves Levaquin generics
- Express Scripts $29.1 billion bid for Medco will hit US FTC scrutiny and squeeze pharma


